Sequential liver and kidney living donors: Making the ultimate gift twice.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
08 2022
Historique:
revised: 01 05 2022
received: 12 10 2021
accepted: 26 05 2022
pubmed: 14 6 2022
medline: 11 8 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

There are nearly 150 living donors in the United States who donated more than one solid organ. Using our divisional database, we found 20 individuals who donated a liver and a kidney at different times. We performed a retrospective chart review of these donors, studying their motivating factors, complications and outcomes. The donors included 11 (55%) males and nine females. Thirteen (65%) donated the kidney before the liver. Fourteen (70%) were nondirected donors at the first donation, and four of the six directed donors in the first donation became nondirected in the second donation. Seventeen (85%) were nondirected at the second donation. Common reasons for donating the second time were a good experience with the first donation and knowing that one can donate again. Outcomes and the incidence of early complications were not significantly different after the 2nd versus the 1st donation. All donors recovered and currently are doing well. Our results show a significant number of dual organ donors are nondirected and motivated by their strong desire to help. A positive experience with the 1st donation often was the driving factor for the 2nd. A history of previous organ donation did not negatively impact the 2nd donation.

Identifiants

pubmed: 35695890
doi: 10.1111/ctr.14750
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14750

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Kirchner VA, Finger EB, Bellin MD, et al. Long-term outcomes for living pancreas donors in the modern era. Transplantation. 2016; 100(6): 1322-1328.
Henderson ML, DiBrito SR, Thomas AG, et al. Landscape of living multiorgan donation in the United States: a registry-based cohort study. Transplantation. 2018; 102(7): 1148-1155.
Fehrman-Ekholm I, Dunér F, Brink B, Tydén G, Elinder CG. No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up. Transplantation. 2001; 72(3): 444-449.
Muzaale AD, Dagher NN, Montgomery RA, Taranto SE, McBride MA, Segev DL. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology. 2012; 142(2): 273-280.
Abecassis MM, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy-a comprehensive report. Am J Transplant. 2012; 12(5): 1208-1217.
Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl. 2013; 19(5): 499-506.
Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303(10): 959-966.
Delanaye P, Weekers L, Dubois BE, et al. Outcome of the living kidney donor. Nephrol Dial Transplant. 2012; 27(1): 41-50.
O'Keeffe LM, Ramond A, Oliver-Williams C, et al. Mid- and long-term health risks in living kidney donors: a systematic review and meta-analysis. Ann Intern Med. 2018; 168(4): 276-284.
Kim Y, Yu MY, Yoo KD, et al. Long-term mortality risks among living kidney donors in Korea. Am J Kidney Dis. 2020; 75(6): 919-925.
Jacobs CL, Gross CR, Messersmith EE, et al. Emotional and financial experiences of kidney donors over the past 50 years: the RELIVE study. Clin J Am Soc Nephrol. 2015; 10(12): 2221-2231.
Nakamura M, Fuchinoue S, Nakajima I, et al. Three cases of sequential liver-kidney transplantation from living-related donors. Nephrol Dial Transplant. 2001; 16(1): 166-168.
Kitajima K, Ogawa Y, Miki K, et al. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor. Liver Transpl. 2017; 23(3): 315-323.
Bramstedt K, Down R. The organ donor experience: Good Samaritans and the meaning of altruism. Rowman & Littlefield; 2011.
Truog RD. The ethics of organ donation by living donors. N Engl J Med. 2005; 353(5): 444-446.
Abecassis M, Adams M, Adams P, et al. Consensus statement on the live organ donor. JAMA. 2000; 284(22): 2919-2926.
Gunby P. Media-abetted liver transplants raise questions of ‘equity and decency. JAMA. 1983; 249(15): 1973-1974.
Veatch RM, Ross LF. Transplantation ethics. Georgetown University Press; 2015.
Williams NJ. On harm thresholds and living organ donation: must the living donor benefit, on balance, from his donation?. Med Health Care Philos. 2018; 21(1): 11-22.
Spital A. Donor benefit is the key to justified living organ donation. Camb Q Healthc Ethics. 2004; 13(1): 105-109.
Elliott C. Doing harm: living organ donors, clinical research and The Tenth Man. J Med Ethics. 1995; 21(2): 91-96.
Jowsey SG, Schneekloth TD. Psychosocial factors in living organ donation: clinical and ethical challenges. Transplant Rev (Orlando). 2008; 22(3): 192-195.
Erim Y, Beckmann M, Valentin-Gamazo C, et al. Quality of life and psychiatric complications after adult living donor liver transplantation. Liver Transpl. 2006; 12(12): 1782-1790.
DiMartini A, Dew MA, Liu Q, et al. Social and financial outcomes of living liver donation: a prospective investigation within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2). Am J Transplant. 2017; 17(4): 1081-1096.
Batson CD, Duncan BD, Ackerman P, Buckley T, Birch K. Is empathic emotion a source of altruistic motivation?. J Pers Soc Psychol. 1981; 40(2): 290.
Sorokin PA. Altruistic love: A study of American“ good neighbors” and Christian saints. Beacon Press; 1950.
Flynn SV, Black LL. An emergent theory of altruism and self-interest. J Couns Dev. 2011; 89(4): 459-469.

Auteurs

Hasan Al Harakeh (H)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Bishoy Emmanuel (B)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Christopher Hughes (C)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Amit Tevar (A)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Jennifer Lynne Steel (JL)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Andrea DiMartini (A)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Swaytha Ganesh (S)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Puneet Sood (P)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Abhinav Humar (A)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH